Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-21

Clinical Trial Update: Regulatory Request NIS in Korea

View source ↗

Summary

Clinical trial update noting regulatory request in Korea for a study involving Type 2 diabetes; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2021-05-21